Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial

Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:24:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:12:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:21:00.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden page, replacing the study content. The additions include a 403 snippet and 'Revision: v3.7.0', while sponsor and MeSH-related metadata were removed.
    Difference
    20%
    Check dated 2026-09-19T18:22:45.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now includes an NIH grant/contract annotation for 2018. The page revision has been updated from v3.6.5 to v3.6.6.
    Difference
    0.2%
    Check dated 2026-08-29T19:40:56.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Sponsor and collaborators information, along with expanded MeSH terms and keywords, have been added to the study record to improve attribution and searchability. The changes also incorporate references like Plan for IPD and related terminology to better describe the study and its context.
    Difference
    69%
    Check dated 2026-08-15T19:18:25.000Z thumbnail image

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.